IL18 and diabetic kidney disease: Studies reveal increased Tim-3 expression in DKD (177), while under renal ischemia-reperfusion injury (IRI), Tim-3 exacerbates kidney damage by upregulating NLRC4 activity, amplifying IL-1β/IL-18-mediated local inflammation.